Biolidics

CATALIST-LISTED medtech firm Biolidics announced on Wednesday (Dec 29) that its wholly-owned subsidiary, Biomedics Laboratory, has been granted approval by the Ministry of Health (MOH) to provide medical microbiology services, including Covid-19 polymerase chain reaction (PCR) tests.

Subject to the company being able to secure sales for its testing services, Biolidics expects the MOH approval to contribute positively to the revenue of the group amid the Covid-19 pandemic for the financial year ending Dec 31, 2022.